WithdrawnPhase 2NCT01835288

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Studying Acute erythroid leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Bruno de Medeiros, MD
Stanford University
Intervention
arsenic trioxide(drug)
Eligibility
18 years · All sexes
Timeline
2013

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01835288 on ClinicalTrials.gov

Other trials for Acute erythroid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute erythroid leukemia →

← Back to all trials